HighTide Therapeutics is dedicated to the discovery and development of innovative therapeutics for people suffering from chronic liver diseases, gastrointestinal diseases and metabolic disorders with large and unsatisfied market needs.
SHENZHEN, CHINA and ROCKVILLE, MD, August 30, 2022 — HighTide Therapeutics, Inc. (“HighTide”), a globally integrated clinical-stage biotechnology company focused on the development of innovative multi-functional therapeutics to address th
SHENZHEN, CHINA and ROCKVILLE, MD, April 28, 2022 — HighTide Therapeutics, Inc. (“HighTide”), a globally integrated clinical-stage biotechnology company developing drugs with multi-functional biological actions to address the complex pathophysiology of me
